A CROSS-SECTIONAL STUDY OF USING BEDSIDE SCREENING TECHNIQUES FOR EVALUATION OF PREVALENCE AND INCIDENCE OF DIABETIC PERIPHERAL NEUROPATHY.

Abstract

Introduction

Peripheral neuropathy is frequently observed in patients with diabetes mellitus who have persistently high blood sugar levels. Diabetic peripheral neuropathy can cause symptoms such as loss of feeling, numbness, or even very upsetting experiences. Significant neuropathic deficits may exist in certain circumstances yet remain undetected. Thus, this research aims to evaluate diabetes mellitus patients to promote early peripheral neuropathy screening.

Methodology

This study included 110 diabetes mellitus patients who visited the Darbhanga Medical College within 2022-2023. A diabetes symptom and examination questionnaire, the tuning fork test, the biothesiometer, the monofilament test, and other bedside screening methods are used in the evaluation.

Results

The results show that people with poor management of their diabetes (51%), after those with fair control (31%) and good control (18%), are most likely to develop diabetic neuropathy. Notably, there is a correlation between blood sugar levels and the severity of peripheral neuropathy. Considering how common diabetic peripheral neuropathy is, it is clear that these individuals' morbidity is still significant.

Conclusion

A major adverse effect of diabetes is diabetic peripheral neuropathy. New treatments like tricyclic anti-depressants or anti-convulsants and proper glycemic control can improve results for these individuals, thus early identification and management are crucial. Initial detection of DPN is crucial for foot ulcer prevention. These folks need extensive preventive treatment and education.

Recommendations

The study suggests that diabetics, especially those with poorly managed blood sugar, should be screened for peripheral neuropathy often. Early detection of neuropathic impairments should prompt therapy and actions to reduce foot ulcer risk. Optimizing glycemic management as part of diabetes patients' regular therapy can lower peripheral neuropathy severity and incidence. To reduce diabetic peripheral neuropathy, patient education should emphasize self-monitoring and foot care.